Having amassed more than 2 million patient years of data, Novartis sits on what is probably one of the most valued treasures in the pharmaceutical industry. But to make sense of it, artificial intelligence, or AI, is only part of the solution. Asking the right questions is crucial to getting the most out of the data. Likewise, when it comes to leprosy, data is only part of the solution to eliminating this disease. But used in the right fashion, it can make a difference in the fight to make leprosy a thing of the past once and for all.

Published on 22/03/2021